Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients

Bone Marrow Transplantation volume 34, pages 1067–1069 (2004)Cite this article

Summary:

Revaccination with poliovirus after allogeneic stem cell transplant (SCT) is usually effective, but the longevity of this immunity is unknown. Therefore, poliovirus immunity was studied in 134 patients having survived at least 5 years after vaccination. The median follow-up from vaccination was 8 years (1–19 years). In all, 21 (15.6%) patients had become seronegative to at least one of the poliovirus serotypes during follow-up. The estimated probabilities of remaining immune to poliovirus at 5 and 10 years after vaccination were 94 and 94% for subtype 1, 98 and 94% for subtype 2, and 93 and 90% for subtype 3, respectively. In multivariate analysis, the only risk factor for loss of immunity was younger patient age (P<0.01), and there was a strong trend for patients with chronic GVHD to lose immunity more rapidly (P=0.07). A total of 14 patients received a booster dose of an inactivated poliovirus vaccine and all responded. We conclude that poliovirus immunity is retained long term after revaccination in most patients after allogeneic SCT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Engelhard D, Handsher R, Naparstek E et al. Immune responses to polio vaccination in bone marrow transplant recipients. Bone Marrow Transplant 1991; 8: 295–300.

    CAS  PubMed  Google Scholar 

  2. Ljungman P, Duraj V, Magnius L . Response to immunization against polio after allogeneic marrow transplantation. Bone Marrow Transplant 1991; 7: 89–93.

    CAS  PubMed  Google Scholar 

  3. Li Volti S, Mauro L, Digregorio F et al. Immune status and immune response to diphtheria–tetanus and polio vaccines in allogeneic bone marrow-transplanted thalassemic patients. Bone Marrow Transplant 1994; 14: 225–227.

    CAS  PubMed  Google Scholar 

  4. Ljungman P, Cordonnier C, de Bock R et al. Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1995; 15: 455–460.

    CAS  PubMed  Google Scholar 

  5. CDC. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. Morb Mortal Wkly Rep 2000; 49: 1–125.

  6. Parkkali T, Stenvik M, Ruutu T et al. Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT. Bone Marrow Transplant 1997; 20: 663–668.

    Article  CAS  PubMed  Google Scholar 

  7. Ringdén O, Bäckman L, Lönnqvist B et al. A randomized trial comparing use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematologic malignancy. Bone Marrow Transplant 1986; 1: 41–49.

    PubMed  Google Scholar 

  8. Ringdén O, Pihlstedt P, Markling L et al. Prevention of graft-versus-host disease with T-cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients. Bone Marrow Transplant 1991; 7: 221–226.

    PubMed  Google Scholar 

  9. Ringdén O, Ruutu T, Remberger M et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group. Blood 1994; 83: 2723–2730.

    PubMed  Google Scholar 

  10. Aschan J, Ringdén O, Andström E et al. Individualized prophylaxis against graft-versus-host disease in leukemic marrow transplant recipients. Bone Marrow Transplant 1994; 14: 79–87.

    CAS  PubMed  Google Scholar 

  11. Ringdén O, Remberger M, Persson U et al. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings. Bone Marrow Transplant 1995; 15: 619–625.

    PubMed  Google Scholar 

  12. Schmidt NJ, Emmons RW . Diagnostic procedures for viral, rickettsial, and chlamydial infections, 6th edn. American Public Health Association: Washington DC, USA, 1989.

    Google Scholar 

  13. Schoub BD, Blackburn NK, McAnerney JM . Seroprevalence to polio in personnel at a virology institute. J Infect 2001; 43: 128–131.

    Article  CAS  PubMed  Google Scholar 

  14. Grotto I, Handsher R, Gdalevich M et al. Decline in immunity to polio among young adults. Vaccine 2001; 19: 4162–4166.

    Article  CAS  PubMed  Google Scholar 

  15. Lum L, Munn N, Schanfield M, Storb R . The detection of specific antibody formation to recall antigens after human bone marrow transplantation. Blood 1986; 67: 582–587.

    CAS  PubMed  Google Scholar 

  16. Remberger M, Kumlien G, Aschan J et al. Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2002; 8: 674–682.

    Article  PubMed  Google Scholar 

  17. Carlens S, Ringden O, Remberger M et al. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant 1998; 22: 755–761.

    Article  CAS  PubMed  Google Scholar 

  18. Sullivan KM, Weiden PL, Storb R et al. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 1989; 73: 1720–1728.

    CAS  PubMed  Google Scholar 

  19. Hammarström V, Pauksen K, Svensson H et al. Tetanus immunity in patients with haematological malignancies. Supp Care Cancer 1998; 6: 469–472.

    Article  Google Scholar 

  20. Ljungman P, Lewensohn-Fuchs I, Hammarstrom V et al. Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation. Blood 1994; 84: 657–663.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by the Swedish Cancer Fund.

Author information

Authors and Affiliations

  1. Karolinska University Hospital, Stockholm, Sweden

    P Ljungman, J Aschan, B Gustafsson, I Lewensohn-Fuchs, J Winiarski & O Ringdén

Authors
  1. P Ljungman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J Aschan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B Gustafsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I Lewensohn-Fuchs
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J Winiarski
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. O Ringdén
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P Ljungman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ljungman, P., Aschan, J., Gustafsson, B. et al. Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients. Bone Marrow Transplant 34, 1067–1069 (2004). https://doi.org/10.1038/sj.bmt.1704678

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704678

Keywords

This article is cited by

Search

Advanced search

Quick links